- Home
- KOD vs NNY Comparison
KOD vs NNY Comparison
Compare KOD & NNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOD
- NNY
- Stock Information
- Founded
- KOD 2009
- NNY 1987
- Country
- KOD United States
- NNY United States
- Employees
- KOD N/A
- NNY N/A
- Industry
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- NNY Investment Managers
- Sector
- KOD Health Care
- NNY Finance
- Exchange
- KOD Nasdaq
- NNY Nasdaq
- Market Cap
- KOD 186.3M
- NNY 163.0M
- IPO Year
- KOD 2018
- NNY N/A
- Fundamental
- Price
- KOD $5.90
- NNY $8.31
- Analyst Decision
- KOD Hold
- NNY
- Analyst Count
- KOD 5
- NNY 0
- Target Price
- KOD $3.50
- NNY N/A
- AVG Volume (30 Days)
- KOD 418.9K
- NNY 50.9K
- Earning Date
- KOD 11-26-2024
- NNY 01-01-0001
- Dividend Yield
- KOD N/A
- NNY 4.04%
- EPS Growth
- KOD N/A
- NNY N/A
- EPS
- KOD N/A
- NNY N/A
- Revenue
- KOD N/A
- NNY N/A
- Revenue This Year
- KOD N/A
- NNY N/A
- Revenue Next Year
- KOD N/A
- NNY N/A
- P/E Ratio
- KOD N/A
- NNY N/A
- Revenue Growth
- KOD N/A
- NNY N/A
- 52 Week Low
- KOD $2.19
- NNY $7.58
- 52 Week High
- KOD $7.77
- NNY $8.87
- Technical
- Relative Strength Index (RSI)
- KOD 80.20
- NNY 38.48
- Support Level
- KOD $5.08
- NNY $8.21
- Resistance Level
- KOD $6.00
- NNY $8.38
- Average True Range (ATR)
- KOD 0.38
- NNY 0.08
- MACD
- KOD 0.06
- NNY -0.00
- Stochastic Oscillator
- KOD 94.14
- NNY 38.46
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.
About NNY Nuveen New York Municipal Value Fund
Nuveen New York Municipal Value Fund Inc is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from both regular federal and New York state income taxes, by investing primarily in a portfolio of municipal obligations issued by state and local government authorities within the state of New York or certain U.S. territories.